Monday, 10 August 2015   
Promising drug for Parkinson's disease
A drug which has already been in use for decades to treat liver disease could be an effective treatment to slow down progression of Parkinson's disease, scientists from the University of Sheffield have discovered. The pioneering research led by academics from the Sheffield Institute of Translational Neuroscience (SITraN), in collaboration with scientists from the University of York, supports the fast-tracking of the drug ursodeoxycholic acid (UDCA) for a clinical trial in Parkinson's patients.
 
Friday, 10 July 2015   
IMI Call for proposals with focus on Alzheimer's disease, diabetes, patient involvement
The Innovative Medicines Initiative (IMI) has launched its 5th Call for proposals under the IMI 2 programme. IMI 2 - Call 5 has a total budget of €95 million and features 6 topics. Of these, four focus on different aspects of Alzheimer's disease, one focuses on diabetic kidney disease, and one addresses patient input on assessments of the benefits and risks of medicines. Four topics focus on Alzheimer's disease, an area where there is an urgent need for new treatments.
 
Tuesday, 07 July 2015   
Vitamin C related to reduced risk of cardiovascular disease and early death
New research from the University of Copenhagen and Herlev and Gentofte Hospital shows that high vitamin C concentrations in the blood from the intake of fruit and vegetables are associated with a reduced risk of cardiovascular disease and early death. Fruit and vegetables are healthy. We all know that. And now there is yet another good reason for eating lots of it. New research from the University of Copenhagen shows that the risk of cardiovascular disease and early death falls with a high intake of fruit and vegetables, and that this may be dued to vitamin C.
 

Research & Development

Promising drug for Parkinson's disease

A drug which has already been in use for decades to treat liver disease could be an effective treatment to...

IMI Call for proposals with focus on Alzheimer's disease, diabetes, patient involvement

The Innovative Medicines Initiative (IMI) has launched its 5th Call for proposals under the IMI 2 programme. IMI 2 -...

Vitamin C related to reduced risk of cardiovascular disease and early death

New research from the University of Copenhagen and Herlev and Gentofte Hospital shows that high vitamin C concentrations in the...

How removing a protein slows blood vessel growth in tumors

Scientists from the University of Leeds and The Institute of Cancer Research, London, have discovered a new protein which triggers...

More in: Research & Development

Conferences & Events

21st Congress of the European Association of Hospital Pharmacists (EAHP)

16 - 18 March 2016, Vienna, Austria. European Association of Hospital Pharmacists (EAHP) is organising the 21st Congress with the theme of 'Hospital pharmacists taking the lead - partnerships and...

The Countdown to eHealth Week 2015

11 - 13 May 2015, Riga, Latvia. Part of the European eHealth Community? Don't miss out on the event of the year. Join eHealth Week 2015 and embark upon three...

eHealth Week 2015 Matchmaking Event

11 - 13 May 2015, Riga, Latvia. eHealth Week 2015 is offering attendees a Matchmaking Event with the aim of encouraging collaboration and generating meaningful global business opportunities between European...

mHealth Summit Europe 2015 and eHealth Week join forces

11 - 12 May 2015, Riga, Latvia. The mHealth Summit Europe will be back in 2015 as a part of eHealth Week in Riga, Latvia. The Summit will be opening...

European Telemedicine Conference 2014

7 - 8 October 2014, Rome, Italy. The European Telemedicine Conference (ETC) 2014 will combine the efforts of several leading European Healthcare Organisations into one powerful event. The conference will...

More in: Conferences & Events

EC Pharmaceuticals

Medicines for children: more research, more availability and more information compared with 5 years ago

News image

Recently, the Commission has publisheed a progress report on medicines for children covering the five years since the Paediatric Regulation came into force. This preliminary snapshot points to improvements in...

New symbol to identify medicines undergoing additional monitoring

News image

An inverted triangle will shortly appear on the inside leaflet of certain medicinal products on the EU market, following a legal act adopted by the European Commission today. The symbol...

Launch of EU Rapid Alert platform for human Tissues and Cells

News image

A secure alert platform launched by the European Commission will improve the safety of patients undergoing transplantation and medical procedures involving human tissues and cells, e.g. bone marrow, cornea, skin,...

Commission proposes faster access to medicines for patients

News image

Medicines should enter the market faster. With this intention the European Commission has proposed today to streamline and reduce the duration of national decisions on pricing and reimbursement of medicines....

Pricing and reimbursement of medicines: Commission consults on EU transparency rules

News image

The European Commission has launched a public consultation in view of modernising rules on the transparency of Member States’ decisions regarding the pricing and reimbursement of medicines. The consultation invites...

More in: European Commission

EMA News

Europe to boost cooperation with international partners on generics

News image

The European Union's decentralised procedure is being used as a model to accelerate the assessment of applications for generic medicines as part of the International Generic Drug Regulators Pilot(IGDRP). The...

European Medicines Agency recommends 39 medicines for human use for marketing authorisation in first half of 2014

News image

Thirty-nine medicines for human use were recommended for marketing authorisation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared...

EMA publishes 2013 annual report

News image

The European Medicines Agency (EMA) has published today its 2013 annual report. In 2013, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended 81 medicines for human use...

Committee for orphan medicines - overview of 2013 and looking ahead

News image

A total of 11 out of 81 medicines recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) in 2013 were intended...

More in: EMA